SynthesisBMC cancer2026

The impact of abiraterone and enzalutamide on hypokalemia incidence in patients with prostate cancer: a systematic review and meta-analysis.

Yibo Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.